telogen effluvium. Telogen effluvium
Conditions
Interventions
Intervention 1: Therapeutic intervention in the first group includes nutritional supplements (folic acid, vitamin D, zincplus and hair vit.) which are prescribed to the person daily for three months b
Sponsors
Bam University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Age 20 to 50 years Covid 19 disease (positive by PCR test) 2 to 4 months before enrollment Occurrence of persistent and significant hair loss after Covid 19 disease, which according to the diagnosis of a dermatologist has a pattern similar to telogen effluvium
Exclusion criteria
Exclusion criteria: People who are diagnosed as the other types of alopecia (except telogen effluvium) Pregnant or lactating women Patients who are being treated with drugs such as finasteride, spironolactone, minoxidil or OCP or who have recently stopped taking these drugs Patients who have an underlying disease affecting hair loss Lack of informed consent to enter the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of hair loss. Timepoint: The beginning of the study , 21 , 42 , 63. Method of measurement: Hair pull test.;The level of satisfaction of the state of hair loss, increased hair growth and hair quality. Timepoint: The beginning of the study , 21 , 42 , 63. Method of measurement: The satisfaction questionnaire is based on the examination of hair loss before and after the intervention, as well as the satisfaction level regarding the state of hair loss, increased hair growth and hair quality based on a five-point scale from very dissatisfied, which means a score of 0, to very satisfied, which means a score of 5. . | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSahar ebrahimi
Bam University of Medical Sciences
Outcome results
None listed